Search Results 1821-1830 of 19330 for prostate cancer
... prostate-specific antigen in prostate cancer. A surrogate biomarker is defined as an indirect measure of disease presence or progression. Emerging evidence ...
Cancer treatment, Stereotactic body radiotherapy, Head and neck cancer, Prostate cancer, Breast cancer, Lung cancer. Roberto A ...
Areas of focus: Cancer treatment, Stereotactic body radiotherapy, Head and neck cancer, Prostate cancer, Breast cancer, Lung cancer ...
Kidney cancer, Prostate cancer, Bladder cancer, Melanoma, Breast cancer. Amye J. Tevaarwerk, M.D.. Oncologist. Rochester, MN. Areas of ...
Carcinoma in situ of the cervix; Prostate cancer < Gleason score 6 with stable prostate-specific antigen (PSA) over 12 months; Ductal breast carcinoma in situ ...
Areas of focus: CT scan, MRI, SPECT scan, Radiopharmaceutical therapy, PET/CT scan, PET/MRI scan, Thyroid cancer, Neuroendocrine tumor,... Prostate cancer.
... prostate or urethra. Antibodies that attack sperm. Anti-sperm ... Increased risk of testicular cancer, melanoma, colon cancer and prostate cancer ...
y cancer, Prostate cancer, Bladder cancer, Rectal cancer, Pancreatic cancer, Esophageal cancer, Liver cancer, Breast cancer, Lung cancer, Bone metastasis.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Benefactor support fuels Mayo Clinic’s groundbreaking research. Make a gift today to help us save lives.